The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS - Sorbonne Université
Conference Papers Year : 2018

The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS

Daniel Gaudet
  • Function : Author
Andres Digenio
  • Function : Author
Veronica Alexander
  • Function : Author
Marcello Arca
  • Function : Author
Alan Jones
  • Function : Author
Erik Stroes
  • Function : Author
Jean Bergeron
  • Function : Author
Fernando Civeira
  • Function : Author
Linda Hemphill
  • Function : Author
Dirk Blom
  • Function : Author
Joann Flaim
  • Function : Author
Steven Hughes
  • Function : Author
Richard Geary
  • Function : Author
Sotirios Tsimikas
  • Function : Author
Eric Bruckert
  • Function : Author
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases

Domains

Life Sciences [q-bio]

Maryse Guerin  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03969811

Submitted on : Thursday, February 2, 2023-2:41:20 PM

Last modification on : Thursday, December 14, 2023-1:50:38 PM

No file

Dates and versions

hal-03969811 , version 1 (02-02-2023)

Identifiers

Cite

Daniel Gaudet, Andres Digenio, Veronica Alexander, Marcello Arca, Alan Jones, et al.. The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS. International Symposium on Atherosclerosis (ISA), Jun 2018, Toronto, Canada. pp.14-15, ⟨10.1016/j.atherosclerosissup.2018.04.042⟩. ⟨hal-03969811⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

ICAN SORBONNE-UNIVERSITE SU-MEDECINE IHU_ICAN
4 View
0 Download

Altmetric

Share

More